Case-mix and the use of control charts in monitoring mortality rates after coronary artery bypass

BackgroundThere is debate about the role of crude mortality rates and case-mix adjusted mortality rates in monitoring the outcomes of treatment. In the context of quality improvement a key purpose of monitoring is to identify special cause variation as this type of variation should be investigated to identify possible causes. This paper investigates agreement between the identification of special cause variation in risk adjusted and observed hospital specific mortality rates after coronary artery bypass grafting in New York hospitals.MethodsCoronary artery bypass grafting mortality rates between 1994 and 2003 were obtained from the New York State Department of Health's cardiovascular reports for 41 hospitals. Cross-sectional control charts of crude (observed) and risk adjusted mortality rates were produced for each year. Special cause variation was defined as a data point beyond the 99.9% probability limits: hospitals showing special cause variation were identified for each year. Longitudinal control charts of crude (observed) and risk adjusted mortality rates were produced for each hospital with data for all ten years (n = 27). Special cause variation was defined as a data point beyond 99.9% probability limits, two out of three consecutive data points beyond 95% probability limits (two standard deviations from the mean) or a run of five consecutive points on one side of the mean. Years showing special cause variation in mortality were identified for each hospital. Cohen's Kappa was calculated for agreement between special causes identified in crude and risk-adjusted control charts.ResultsIn cross sectional analysis the Cohen's Kappa was 0.54 (95% confidence interval: 0.28 to 0.78), indicating moderate agreement between the crude and risk-adjusted control charts with sensitivity 0.4 (95% confidence interval 0.17–0.69) and specificity 0.98 (95% confidence interval: 0.95–0.99). In longitudinal analysis, the Cohen's Kappa was 0.61 (95% confidence interval: 0.39 to 0.83) indicating good agreement between the tests with sensitivity 0.63 (95% confidence interval: 0.39–0.82) and specificity 0.98 (95% confidence interval: 0.96 to 0.99).ConclusionThere is moderate-good agreement between signals of special cause variation between observed and risk-adjusted mortality. Analysis of observed hospital specific CABG mortality over time and with other hospitals appears to be useful in identifying special causes of variation. Case-mix adjustment may not be essential for longitudinal monitoring of outcomes using control charts.

[1]  Richard Lilford,et al.  Use and misuse of process and outcome data in managing performance of acute medical care: avoiding institutional stigma , 2004, The Lancet.

[2]  E L Hannan,et al.  Clinical Versus Administrative Data Bases for CABG Surgery: Does it Matter , 1992, Medical care.

[3]  L. Iezzoni,et al.  Judging hospitals by severity-adjusted mortality rates: the case of CABG surgery. , 1996, Inquiry : a journal of medical care organization, provision and financing.

[4]  S L Normand,et al.  Cardiac surgery report cards: comprehensive review and statistical critique. , 2001, The Annals of thoracic surgery.

[5]  Alex Bottle,et al.  Trends in admissions and deaths in English NHS hospitals , 2004, BMJ : British Medical Journal.

[6]  Raymond G. Carey,et al.  Improving Healthcare with Control Charts: Basic and Advanced SPC Methods and Case Studies , 2002 .

[7]  M. Amrani,et al.  An evaluation of existing risk stratification models as a tool for comparison of surgical performances for coronary artery bypass grafting between institutions. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[8]  Lloyd S. Nelson,et al.  Column: Technical Aids: The Shewhart Control Chart--Tests for Special Causes , 1984 .

[9]  A. R. Crathorne,et al.  Economic Control of Quality of Manufactured Product. , 1933 .

[10]  C. Beguin,et al.  Systematic analysis of in-patients' circumstances and causes of death: a tool to improve quality of care. , 1997, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[11]  Chris Sherlaw-Johnson,et al.  Monitoring the results of cardiac surgery by variable life-adjusted display , 1997, The Lancet.

[12]  Jones Mark,et al.  Surgeon specific mortality in adult cardiac surgery: comparison between crude and risk stratified data , 2003, BMJ : British Medical Journal.

[13]  T. Marshall,et al.  Differences in clinical performance , 2002, The British journal of surgery.

[14]  Jacob Cohen A Coefficient of Agreement for Nominal Scales , 1960 .

[15]  S. Olenchock,et al.  Comparative analysis of risk-adjusted bypass surgery stratification models in a community hospital. , 2003, Heart & lung : the journal of critical care.

[16]  M. Chassin,et al.  Achieving and sustaining improved quality: lessons from New York State and cardiac surgery. , 2002, Health affairs.

[17]  L. Nobilio,et al.  Risk adjustment for coronary artery bypass graft surgery: an administrative approach versus EuroSCORE. , 2004, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[18]  R. Écochard,et al.  Fair comparison of mortality data following cardiac surgery , 2000, Heart.

[19]  D. Asch,et al.  The unintended consequences of publicly reporting quality information. , 2005, JAMA.

[20]  F. Billari,et al.  does it matter? , 2007 .

[21]  T. Osler,et al.  Comparing outcomes of coronary artery bypass surgery: Is the New York Cardiac Surgery Reporting System model sensitive to changes in case mix? , 2001, Critical care medicine.

[22]  Martin Bland,et al.  Properties of the Cumulative Risk-Adjusted Mortality (CRAM) Chart, Including the Number of Deaths Before a Doubling of the Death Rate is Detected , 2003, Medical decision making : an international journal of the Society for Medical Decision Making.

[23]  Tom Marshall,et al.  Performance league tables: the NHS deserves better , 2002, BMJ : British Medical Journal.

[24]  F. Song,et al.  Evaluating non-randomised intervention studies. , 2003, Health technology assessment.

[25]  Tom Marshall,et al.  Bristol, Shipman, and clinical governance: Shewhart's forgotten lessons , 2001, The Lancet.

[26]  L I Iezzoni,et al.  The risks of risk adjustment. , 1997, JAMA.